Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder
- PMID: 15667315
- DOI: 10.1042/BST0330233
Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder
Abstract
Hartnup disorder is an autosomal recessive abnormality of renal and gastrointestinal neutral amino acid transport. A corresponding transport activity has been characterized in kidney and intestinal cells and named system B(0). The failure to resorb amino acids in this disorder is thought to be compensated by a protein-rich diet. However, in combination with a poor diet and other factors, more severe symptoms can develop in Hartnup patients, including a photosensitive pellagra-like skin rash, cerebellar ataxia and other neurological symptoms. Homozygosity mapping in a Japanese family and linkage analysis on six Australian pedigrees placed the Hartnup disorder gene at a locus on chromosome 5p15. This fine mapping facilitated a candidate gene approach within the interval, which resulted in the cloning and characterization of a novel member of the sodium-dependent neurotransmitter transporter family (B(0)AT1, SLC6A19) from mouse and human kidney, which shows all properties of system B(0). Flux experiments and electrophysiological recording showed that the transporter is Na(+) dependent and Cl(-) independent, electrogenic and actively transports most neutral amino acids. In situ hybridization showed strong expression in intestinal villi and in the proximal tubule of the kidney. Expression of B(0)AT1 was restricted to kidney, intestine and skin. A total of ten mutations have been identified in SLC6A19 that co-segregate with disease in the predicted recessive manner, with the majority of affected individuals being compound heterozygotes. These mutations lead to altered neutral amino acid transport function compared to the wild-type allele in vitro. One of the mutations occurs in members of the original Hartnup family described in 1956, thereby defining SLC6A19 as the 'Hartnup'-gene.
Similar articles
-
Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.Nat Genet. 2004 Sep;36(9):999-1002. doi: 10.1038/ng1405. Epub 2004 Aug 1. Nat Genet. 2004. PMID: 15286787
-
Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.Nat Genet. 2004 Sep;36(9):1003-7. doi: 10.1038/ng1406. Epub 2004 Aug 1. Nat Genet. 2004. PMID: 15286788
-
Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder.J Biol Chem. 2004 Jun 4;279(23):24467-76. doi: 10.1074/jbc.M400904200. Epub 2004 Mar 25. J Biol Chem. 2004. PMID: 15044460
-
Novel mutation in SLC6A19 causing late-onset seizures in Hartnup disorder.Pediatr Neurol. 2010 May;42(5):369-71. doi: 10.1016/j.pediatrneurol.2010.01.009. Pediatr Neurol. 2010. PMID: 20399395 Review.
-
The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition.IUBMB Life. 2009 Jun;61(6):591-9. doi: 10.1002/iub.210. IUBMB Life. 2009. PMID: 19472175 Free PMC article. Review.
Cited by
-
New aspects for the brain in Hartnup disease based on mining of high-resolution cellular mRNA expression data for SLC6A19.IBRO Neurosci Rep. 2023 Mar 25;14:393-397. doi: 10.1016/j.ibneur.2023.03.010. eCollection 2023 Jun. IBRO Neurosci Rep. 2023. PMID: 37101820 Free PMC article. Review.
-
Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice.Dis Model Mech. 2023 May 1;16(5):dmm049647. doi: 10.1242/dmm.049647. Epub 2022 Nov 14. Dis Model Mech. 2023. PMID: 36374036 Free PMC article.
-
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.Adv Exp Med Biol. 2021;21:13-127. doi: 10.1007/5584_2020_584. Adv Exp Med Biol. 2021. PMID: 33052588 Review.
-
Mice Lacking the Intestinal and Renal Neutral Amino Acid Transporter SLC6A19 Demonstrate the Relationship between Dietary Protein Intake and Amino Acid Malabsorption.Nutrients. 2019 Aug 29;11(9):2024. doi: 10.3390/nu11092024. Nutrients. 2019. PMID: 31470570 Free PMC article.
-
Development of Biomarkers for Inhibition of SLC6A19 (B⁰AT1)-A Potential Target to Treat Metabolic Disorders.Int J Mol Sci. 2018 Nov 14;19(11):3597. doi: 10.3390/ijms19113597. Int J Mol Sci. 2018. PMID: 30441827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials